January 31, 2018
Rose
Halo Neuroscience, a device company that develops and sells the Halo Sport neurostimulation headset, announced yesterday that it has secured $13 million in Series B funding. Global private investment firm TPG led the round, which also had participation from prior investors Lux Capital, JAZZ Ventures Partners, and Xfund.
from MobiHealthNews http://ift.tt/2nwNl9t
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment